We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany

By LabMedica International staff writers
Posted on 24 Nov 2021

The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19. More...

The biannual EuroMedLab congress is jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC; Lombardia, Italy), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM; Milano, Italy), and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL; Berlin, Germany). The event has proven to be one of the leading forums to bring together scientists, laboratory specialists, clinicians, and industry colleagues in the field of clinical chemistry and laboratory medicine.

The 24th EuroMedLab would have been the first major IFCC/EFLM conference to be held following a long delay caused by the pandemic and was expected to provide an excellent opportunity to bring together laboratory specialists from many national societies both physically and virtually. At EuroMedLab Congress 2021, attendees were expected to experience the outstanding scientific program, featuring innovative and diverse educational opportunities that incorporate the best of clinical laboratory medicine and in vitro diagnostics, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and much more. In addition to the scientific program, excellent social opportunities had been organized for the attendees to enjoy many attractions in Munich.

However, at a time when the EuroMedLab Congress 2021 was in the final stages of preparation, Germany has been hit very hard by a fourth COVID-19 wave, particularly in the area of the venue in Munich. Travel warnings for Germany have been issued by some countries even for vaccinated individuals, making it potentially problematic to return home after the congress. The local government has announced lockdowns for the coming days in all areas, where the seven-day incidences exceed 1,000 in 100,000. Munich as the EuroMedLab venue is approaching this threshold. Keeping in mind the safety of all attendees, exhibitors and staff, the organizers have decided that an orderly meeting cannot be warranted under these conditions. Therefore, IFCC and EFLM, together with the Congress Organizing Committee have decided to postpone EuroMedLab Congress 2021. The organizers are currently looking into rescheduling in 2022 and will communicate a new date for the conference in the near future.

Related Links:
IFCC 
EFLM 
DGKL


Gold Member
Serological Pipets
INTEGRA Serological Pipets
Collection and Transport System
PurSafe Plus®
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test analyzes biomarkers in uterine fluid to detect endometrial cancer (Photo courtesy of 123RF)

ELISA-Based Test Uses Gynecologic Fluids to Detect Endometrial Cancer

Every year, 35 million postmenopausal women worldwide experience abnormal uterine bleeding (AUB), the primary trigger for initiating endometrial cancer diagnosis. Around 5% of these women will develop... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.